NBT Bank’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-157
Closed -$28.8K 1055
2025
Q4
$28.8K Hold
157
﹤0.01% 559
2025
Q3
$24K Hold
157
﹤0.01% 581
2025
Q2
$21.9K Hold
157
﹤0.01% 583
2025
Q1
$23K Hold
157
﹤0.01% 578
2024
Q4
$20.5K Sell
157
-300
-66% -$42K ﹤0.01% 594
2024
Q3
$71.1K Buy
+457
New +$73.8K ﹤0.01% 480

Other funds holding AZN

NBT Bank's AZN Position: Q1 2026 in Review

NBT Bank sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 157 shares — an estimated $28.8K sold.

NBT Bank first reported a position in AZN in Q3 2024 and held it in 6 quarters. The position peaked at $71.1K in Q3 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • NBT Bank reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • NBT Bank sold 157 AstraZeneca shares in Q1 2026, an estimated $28.8K.
  • NBT Bank first reported a position in AstraZeneca in Q3 2024 and held it in 6 quarters.
  • NBT Bank's AstraZeneca position peaked at $71.1K in Q3 2024.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on NBT Bank's 13F filing for Q1 2026, filed 28 Apr 2026.